{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "binds",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ00528",
      "entity_text" : "IgG",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uniprot:P55899",
      "entity_text" : "FcRn",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false,
    "context" : {
      "TissueType" : [ "tissuelist:TS-0923" ],
      "CellType" : [ "cl:CL:0000066" ],
      "Species" : [ "taxonomy:9606" ]
    }
  },
  "verbose_text" : "Especially, engineering of FcRn binding and transport of IgG has resulted in development of therapeutic IgGs and IgG derived Fc fusions with improved serum half-life XREF_BIBR XREF_BIBR XREF_BIBR XREF_BIBR XREF_BIBR.",
  "reading_complete" : "2020-08-04T11:33:17Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-04T11:32:16Z",
  "trigger" : "binding",
  "evidence" : [ "FcRn binding and transport of IgG" ],
  "pmc_id" : "3552320",
  "score" : 0
}